QuantLogix ← CME scorecard
📅 CME Earnings Preview
CME Group Inc.
Next report (est.)
11/13/2026
Countdown
67 days
EPS growth YoY
+2.5%
Revenue growth YoY
+0.8%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
07/24/2026 ±3.5% +0.4% over-priced
04/24/2026 ±2.8% -0.1% over-priced
10/24/2025 ±2.1% +0.2% over-priced
07/25/2025 ±1.8% +0.9% over-priced
04/30/2025 ±2.6% +1.7% over-priced
11/08/2024 ±2.1% +1.6% over-priced
08/05/2024 ±2.1% -1.3% over-priced
05/01/2024 ±2.1% -0.8% over-priced
Across these reports, options implied an average ±2.4% move vs an actual average of 0.9% — the stock stayed inside the implied band 100% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $2.88 $1.7B $1.0B
Q1 FY2026 $3.18 $1.9B $1.2B
Q4 FY2025 $3.24 $1.6B $1.2B
Q3 FY2025 $2.49 $1.5B $908M
Analyst posture
Buy / Strong Buy
11
Hold
7
Sell
3
Stable: -1 net change 30d
Live 5-factor engine read: Neutral · 49/100 Full scorecard →
Get alerted before every CME report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CME before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

CME Group Inc. (CME) reports in 67 days, with the next report estimated for 11/13/2026. Across the last 8 reports, options priced an average ±2.4% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced CME's earnings risk. Fundamentals into the print: EPS up 2.5% year-over-year, revenue up 0.8%. QuantLogix's live 5-factor engine currently reads CME as a neutral at 49/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →